Medacta's AGM Approves All Board Proposals

Medacta Group SA announced that its Annual General Meeting (AGM), held on May 7, 2025, confirmed all proposals by the Board of Directors. Shareholders approved a distribution of CHF 13.7 million, equating to CHF 0.69 per share, split equally between dividends from earnings and capital contribution reserves. Dr. Alberto Siccardi was re-elected as Chair, with all board members standing for re-election also reaffirmed for another year.

The AGM witnessed the attendance of shareholders and proxies, with a representation of 89.41% of Medacta's share capital. The meeting approved financial reports and discharged the Board's responsibilities for 2024. Additionally, all were re-elected, including Philippe Weber and Riccardo Braglia to the Remuneration Committee, and the independent proxy and auditors.